Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corneel Coens

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 17, 2016
Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patientsDivine E Ediebah, Jaap C Reijneveld, Martin J B Taphoorn, et al.
Future Oncology (London, England)|November 28, 2025
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastasesBertrand Tombal, Fred Saad, Enrique Gallardo, et al.
The Lancet. Oncology|December 5, 2019
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic reviewJustyna Mierzynska, Claire Piccinin, Madeline Pe, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2010
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patientsMartin J B Taphoorn, Lily Claassens, Neil K Aaronson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2008
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancerGeorge van Andel, Andrew Bottomley, Sophie D Fosså, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2022
Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72]Michael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of CancerFabio Efficace, Pasquale F Innominato, Georg Bjarnason, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2022
Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trialsMichael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
BMC Cancer|October 8, 2021
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trialsEva M Gamper, Jammbe Z Musoro, Corneel Coens, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanomaJammbe Z Musoro, Andrew Bottomley, Corneel Coens, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 17, 2016
Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patientsDivine E Ediebah, Jaap C Reijneveld, Martin J B Taphoorn, et al.
Future Oncology (London, England)|November 28, 2025
A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastasesBertrand Tombal, Fred Saad, Enrique Gallardo, et al.
The Lancet. Oncology|December 5, 2019
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic reviewJustyna Mierzynska, Claire Piccinin, Madeline Pe, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2010
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patientsMartin J B Taphoorn, Lily Claassens, Neil K Aaronson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2008
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancerGeorge van Andel, Andrew Bottomley, Sophie D Fosså, et al.
Lung Cancer (Amsterdam, Netherlands)|May 23, 2022
Corrigendum to "Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials" [Lung Cancer 167C (2022) 65-72]Michael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of CancerFabio Efficace, Pasquale F Innominato, Georg Bjarnason, et al.
Lung Cancer (Amsterdam, Netherlands)|April 12, 2022
Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trialsMichael Koller, Jammbe Z Musoro, Krzysztof Tomaszewski, et al.
BMC Cancer|October 8, 2021
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trialsEva M Gamper, Jammbe Z Musoro, Corneel Coens, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2018
Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanomaJammbe Z Musoro, Andrew Bottomley, Corneel Coens, et al.
Pageof 13